Intuitive Surgical, Inc. $ISRG Shares Sold by Danske Bank A S

Danske Bank A S decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.6% in the 3rd quarter, Holdings Channel reports. The fund owned 369,566 shares of the medical equipment provider’s stock after selling 43,845 shares during the quarter. Danske Bank A S’s holdings in Intuitive Surgical were worth $150,277,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in ISRG. Fairscale Capital LLC lifted its position in Intuitive Surgical by 3.5% in the 3rd quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock valued at $279,000 after acquiring an additional 22 shares in the last quarter. Beaumont Financial Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.8% during the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 23 shares in the last quarter. Hughes Financial Services LLC grew its stake in shares of Intuitive Surgical by 40.7% during the 3rd quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 24 shares in the last quarter. Blue Fin Capital Inc. raised its holdings in shares of Intuitive Surgical by 0.5% in the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock valued at $2,210,000 after purchasing an additional 25 shares during the last quarter. Finally, Red Spruce Capital LLC raised its holdings in shares of Intuitive Surgical by 4.1% in the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock valued at $255,000 after purchasing an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded up $3.70 during mid-day trading on Friday, hitting $443.59. The stock had a trading volume of 1,604,248 shares, compared to its average volume of 2,787,457. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The stock has a market cap of $153.77 billion, a price-to-earnings ratio of 53.64, a PEG ratio of 3.03 and a beta of 1.45. The company’s 50 day simple moving average is $417.59 and its 200 day simple moving average is $429.98.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period in the previous year, the firm earned $2.40 EPS. The firm’s revenue was up 21.7% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. BTIG Research reissued a “buy” rating and set a $454.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Barclays restated an “overweight” rating and issued a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Mizuho lowered their target price on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 21st. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 20,095 shares of the business’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the sale, the director owned 1,204,530 shares of the company’s stock, valued at $543,977,793.30. The trade was a 1.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the sale, the vice president owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 39,456 shares of company stock valued at $17,769,124 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.